Fate Therapeutics is a clinical-stage biopharmaceutical company that specializes in developing immunotherapies for various cancer and immune disorders worldwide. They have multiple programs in development, including treatments for acute myeloid leukemia and B-cell lymphoma. The company also has several collaborations and agreements with other pharmaceutical companies to further their research and development efforts.